| pubmed-article:19014884 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19014884 | lifeskim:mentions | umls-concept:C0014996 | lld:lifeskim |
| pubmed-article:19014884 | lifeskim:mentions | umls-concept:C0384601 | lld:lifeskim |
| pubmed-article:19014884 | lifeskim:mentions | umls-concept:C0243076 | lld:lifeskim |
| pubmed-article:19014884 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:19014884 | pubmed:dateCreated | 2008-12-26 | lld:pubmed |
| pubmed-article:19014884 | pubmed:abstractText | The synthesis and identification of sulfonamido-aryl ethers as potent bradykinin B1 receptor antagonists from a approximately 60,000 member encoded combinatorial library are reported. Two distinct series of compounds exhibiting different structure-activity relationships were identified in a bradykinin B1 whole-cell receptor-binding assay. Specific examples exhibit K(i) values of approximately 10nM. | lld:pubmed |
| pubmed-article:19014884 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19014884 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19014884 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19014884 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19014884 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19014884 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19014884 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19014884 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19014884 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:19014884 | pubmed:issn | 1464-3405 | lld:pubmed |
| pubmed-article:19014884 | pubmed:author | pubmed-author:SchneiderPete... | lld:pubmed |
| pubmed-article:19014884 | pubmed:author | pubmed-author:BresciaMarc-R... | lld:pubmed |
| pubmed-article:19014884 | pubmed:author | pubmed-author:RitchieTimoth... | lld:pubmed |
| pubmed-article:19014884 | pubmed:author | pubmed-author:HallettAllanA | lld:pubmed |
| pubmed-article:19014884 | pubmed:author | pubmed-author:HendersonIanI | lld:pubmed |
| pubmed-article:19014884 | pubmed:author | pubmed-author:McDonaldEdwar... | lld:pubmed |
| pubmed-article:19014884 | pubmed:author | pubmed-author:DolleRoland... | lld:pubmed |
| pubmed-article:19014884 | pubmed:author | pubmed-author:GanjuPamP | lld:pubmed |
| pubmed-article:19014884 | pubmed:author | pubmed-author:MetzgerAxelA | lld:pubmed |
| pubmed-article:19014884 | pubmed:author | pubmed-author:BrainChristop... | lld:pubmed |
| pubmed-article:19014884 | pubmed:author | pubmed-author:AppellKenneth... | lld:pubmed |
| pubmed-article:19014884 | pubmed:author | pubmed-author:BaldwinJohn... | lld:pubmed |
| pubmed-article:19014884 | pubmed:author | pubmed-author:GstachHubertH | lld:pubmed |
| pubmed-article:19014884 | pubmed:author | pubmed-author:BevanStuart... | lld:pubmed |
| pubmed-article:19014884 | pubmed:author | pubmed-author:PatelViralV | lld:pubmed |
| pubmed-article:19014884 | pubmed:author | pubmed-author:ColeAndrew... | lld:pubmed |
| pubmed-article:19014884 | pubmed:author | pubmed-author:OakleyPaul... | lld:pubmed |
| pubmed-article:19014884 | pubmed:author | pubmed-author:McBrydeAndrew... | lld:pubmed |
| pubmed-article:19014884 | pubmed:author | pubmed-author:QinLan-YingLY | lld:pubmed |
| pubmed-article:19014884 | pubmed:author | pubmed-author:DenholmAlasta... | lld:pubmed |
| pubmed-article:19014884 | pubmed:author | pubmed-author:WareingJames... | lld:pubmed |
| pubmed-article:19014884 | pubmed:author | pubmed-author:DrakeGillian... | lld:pubmed |
| pubmed-article:19014884 | pubmed:author | pubmed-author:MacGloinnAisl... | lld:pubmed |
| pubmed-article:19014884 | pubmed:author | pubmed-author:NunezXimenaX | lld:pubmed |
| pubmed-article:19014884 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19014884 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:19014884 | pubmed:volume | 19 | lld:pubmed |
| pubmed-article:19014884 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19014884 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19014884 | pubmed:pagination | 119-22 | lld:pubmed |
| pubmed-article:19014884 | pubmed:meshHeading | pubmed-meshheading:19014884... | lld:pubmed |
| pubmed-article:19014884 | pubmed:meshHeading | pubmed-meshheading:19014884... | lld:pubmed |
| pubmed-article:19014884 | pubmed:meshHeading | pubmed-meshheading:19014884... | lld:pubmed |
| pubmed-article:19014884 | pubmed:meshHeading | pubmed-meshheading:19014884... | lld:pubmed |
| pubmed-article:19014884 | pubmed:meshHeading | pubmed-meshheading:19014884... | lld:pubmed |
| pubmed-article:19014884 | pubmed:meshHeading | pubmed-meshheading:19014884... | lld:pubmed |
| pubmed-article:19014884 | pubmed:meshHeading | pubmed-meshheading:19014884... | lld:pubmed |
| pubmed-article:19014884 | pubmed:meshHeading | pubmed-meshheading:19014884... | lld:pubmed |
| pubmed-article:19014884 | pubmed:meshHeading | pubmed-meshheading:19014884... | lld:pubmed |
| pubmed-article:19014884 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19014884 | pubmed:articleTitle | Sulfonamido-aryl ethers as bradykinin B1 receptor antagonists. | lld:pubmed |
| pubmed-article:19014884 | pubmed:affiliation | Pharmacopeia Inc, Princeton, NJ 08543, USA. acole@pcop.com | lld:pubmed |
| pubmed-article:19014884 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:19014884 | lld:chembl |
